Vetticaden Santosh 4
4 · CUBIST PHARMACEUTICALS INC · Filed Oct 28, 2011
Insider Transaction Report
Form 4
Vetticaden Santosh
SVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2011-10-26$22.66/sh+55,000$1,246,300→ 63,433 total - Sale
Common Stock
2011-10-26$38.60/sh−55,000$2,122,973→ 8,433 total - Exercise/Conversion
Stock Options (Right to Buy)
2011-10-26−55,000→ 25,000 totalExercise: $22.66From: 2009-04-15Exp: 2019-01-15→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]Option vests 6.25% quarterly over a four-year period.
- [F2]This transaction was executed in multiple trades at prices ranging from $38.1850 to $38.81. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.